LARC-GAPs: emerging whole-sporozoite vaccines for high-level sterile protection against malaria.

Authors

Plabita Paul, Indrani Chakraborty, Raksha Devi, Satish Mishra

Published in

Trends in parasitology. Sep 22, 2026. Epub Sep 22, 2026.

Abstract

Malaria remains a major global health challenge. Despite the recent deployment of the RTS,S/AS01 and R21/Matrix-M vaccines, malaria cases and deaths continue to increase. Although these vaccines are a major achievement, their protection is incomplete and wanes over time. Whole-sporozoite vaccines are the most effective malaria vaccines targeting the pre-erythrocytic stage. Among them, genetically attenuated parasites (GAPs) have shown advantages over other vaccine approaches. Recent studies have shown that late liver-stage-arresting, replication-competent (LARC)-GAPs elicit broader immune responses and provide better protection than other malaria vaccines. Here, we highlight the development of GAP vaccines, compare early-arresting GAPs and LARC-GAPs, discuss recent clinical data, and assess their translational potential as next-generation malaria vaccines.

PMID:
42838833
Bibliographic data and abstract were imported from PubMed on 07 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.